Literature DB >> 8025711

Inhibition of neuronal activity in the nucleus of the optic tract due to electrical stimulation of the medial terminal nucleus in the rat.

C van der Togt1, M Schmidt.   

Abstract

Morphologically, a GABAergic connection between the medial terminal nucleus of the accessory optic system and the nucleus of the optic tract, two primary visual nuclei involved in the optokinetic reflex, has been demonstrated. In this study it was investigated if the medial terminal nucleus forms an inhibitory input to movement direction selective units in the nucleus of the optic tract. Neurons in the nucleus of the optic tract were visually stimulated with moving large random square patterns in their preferred and non-preferred direction, and their activity was recorded extracellularly. Concomitantly, bipolar electrical stimulation was applied to the medial terminal nucleus and its effect was studied on the visual responses of units in the nucleus of the optic tract. Units in the nucleus of the optic tract were strongly inhibited during electrical stimulation of the medial terminal nucleus. The role of GABA in mediating this inhibition was investigated by applying bicuculline, a GABAA receptor antagonist, iontophoretically to the recorded units in the nucleus of the optic tract. However, although average spike rate levels of units in the nucleus of the optic tract increased with bicuculline, bicuculline did not reduce inhibition invoked by electrical stimulation of the medial terminal nucleus. A possible explanation for this observation is that this inhibition is GABAB receptor mediated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8025711     DOI: 10.1111/j.1460-9568.1994.tb00300.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  1 in total

1.  Contribution of GABA(C) receptors to inhibition in the rodent accessory optic system.

Authors:  Katja Schlicker; Matthias Schmidt
Journal:  Exp Brain Res       Date:  2009-11-10       Impact factor: 1.972

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.